BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/10/2021 7:23:16 AM | Browse: 360 | Download: 620
Publication Name World Journal of Clinical Cases
Manuscript ID 68908
Country/Territory China
Received
2021-06-08 07:32
Peer-Review Started
2021-06-08 07:35
To Make the First Decision
Return for Revision
2021-06-30 10:58
Revised
2021-07-09 09:11
Second Decision
2021-07-28 05:09
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2021-07-28 07:41
Articles in Press
2021-07-28 07:41
Publication Fee Transferred
Edit the Manuscript by Language Editor
2021-08-09 22:47
Typeset the Manuscript
2021-09-06 06:55
Publish the Manuscript Online
2021-09-10 07:23
ISSN 2307-8960 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Medicine, Research & Experimental
Manuscript Type Minireviews
Article Title Combined targeted therapy and immunotherapy for cancer treatment
Manuscript Source Invited Manuscript
All Author List Cheng-Xiang Guo, Xing Huang, Jian Xu, Xiao-Zhen Zhang, Yi-Nan Shen, Ting-Bo Liang and Xue-Li Bai
ORCID
Author(s) ORCID Number
Cheng-Xiang Guo http://orcid.org/0000-0002-9542-5532
Xing Huang http://orcid.org/0000-0002-8886-2777
Jian Xu http://orcid.org/0000-0001-8132-8988
Xiao-Zhen Zhang http://orcid.org/0000-0003-3567-8789
Yi-Nan Shen http://orcid.org/0000-0003-4193-7206
Ting-Bo Liang http://orcid.org/0000-0003-0143-3353
Xue-Li Bai http://orcid.org/0000-0002-2934-0880
Funding Agency and Grant Number
Funding Agency Grant Number
the National Key Research and Development Program of China 2019YFC1316000
the National High Technology Research and Development Program of China 2015AA020405
the National Natural Science Foundation of China 81672337
China Postdoctoral Science Foundation 2020M671761
Corresponding Author Xue-Li Bai, MD, PhD, Chief Doctor, Executive Vice President, Professor, Research Scientist, Surgeon, Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, No. 79 Qingchun Road , Hangzhou 310003, Zhejiang Province, China. shirleybai@zju.edu.cn
Key Words Cancer; Targeted therapy; Immunotherapy; Combined treatment
Core Tip There has been considerable interest in combining systemic and immune-related therapies for the anti-tumor treatment of various cancer types. Additional insights into the effects and mechanisms of targeted therapies on the induction of antitumor immunity will aid the development and design of rational and effective combination strategies, with the synergistic potential for rapid tumor regression and a durable response. Alternatively, targeting specific signaling pathways may also help in overcoming the mechanisms of immunotherapy resistance. In this study, we briefly review the immunomodulatory effects of combinations of targeted therapies and immunotherapies, and discusses the obstacles associated with them, which may be useful for the development of novel basic research or clinical trials.
Publish Date 2021-09-10 07:23
Citation Guo CX, Huang X, Xu J, Zhang XZ, Shen YN, Liang TB, Bai XL. Combined targeted therapy and immunotherapy for cancer treatment. World J Clin Cases 2021; 9(26): 7643-7652
URL https://www.wjgnet.com/2307-8960/full/v9/i26/7643.htm
DOI https://dx.doi.org/10.12998/wjcc.v9.i26.7643
Full Article (PDF) WJCC-9-7643.pdf
Full Article (Word) WJCC-9-7643.docx
Manuscript File 68908-Review-FilipodiaCL.docx
Answering Reviewers 68908-Answering reviewers.pdf
Audio Core Tip 68908-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 68908-Conflict-of-interest statement.pdf
Copyright License Agreement 68908-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s) 68908-Grant application form(s).pdf
Non-Native Speakers of English Editing Certificate 68908-Language certificate.pdf
Peer-review Report 68908-Peer-review(s).pdf
Scientific Misconduct Check 68908-Bing-Chang KL-2.jpg
Scientific Misconduct Check 68908-Scientific misconduct check.pdf
Scientific Editor Work List 68908-Scientific editor work list.pdf